10 Worst ARK Stocks To Buy According to Short Sellers
Cathie Wood of ARK Investment is one of Wall Street's most well-known hedge fund bosses.
Pacific Biosciences Of California Inc. (PACB)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | ARK Investment Management Catherine D. Wood | 33,406,401 | $56,790,882 | +1% | 0.51% |
| 2. | Millennium Management Israel Englander | 10,422,578 | $17,718,383 | +126% | 0% |
| 3. | Marshall Wace LLP Paul Marshall And Ian Wace | 2,121,920 | $3,607,264 | +32% | 0% |
| 4. | Soros Fund Management George Soros | 2,098,000 | $3,566,600 | +24% | 0.05% |
| 5. | Rima Senvest Management Richard Mashaal | 1,093,954 | $1,859,722 | +37% | 0.06% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $4.40 | 40,000 | Director | 40,000 | 2024-03-06 | Filing | |
| $2.01 | 1 | Officer | 215,156 | 2018-09-01 | Filing | |
| $2.01 | 5,989 | Officer | 215,155 | 2018-03-01 | Filing | |
| $4.07 | 3,244 | Officer | 194,166 | 2017-09-01 | Filing | |
| $4.07 | 3,212 | Officer | 190,922 | 2017-03-01 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $1.72 | 19,782 | Officer | 695,654 | 2024-09-30 | Filing | |
| $1.75 | 98,907 | Officer | 2,497,763 | 2024-09-16 | Filing | |
| $1.59 | 26,760 | Officer | 869,730 | 2024-08-19 | Filing | |
| $1.66 | 38,011 | Officer | 1,630,815 | 2024-08-16 | Filing | |
| $2.03 | 5,275 | Officer | 211,941 | 2024-05-20 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 26,789,552 | $262,805,506 | 0% | |
| 2. | 24,642,666 | $241,744,552 | 0% | |
| 3. | 17,591,915 | $172,576,686 | 21.5% | |
| 4. | 13,200,375 | $129,627,683 | 1.24% | |
| 5. | 13,200,375 | $129,495,679 | 0.09% |
News See All
10 Best Genomics Stocks To Buy Right Now
Genomics is the study of genes and how they function.
Pacific Biosciences of California, Inc. (NASDAQ:PACB) Q3 2024 Earnings Call Transcript
Pacific Biosciences of California, Inc. (NASDAQ:PACB) Q3 2024 Earnings Call Transcript November 7, 2024Pacific Biosciences of California, Inc. beats earnings expectations.
10 Most Promising Gene Editing Stocks to Buy According to Hedge Funds
The pharmaceutical industry remains a hub of patent innovation, driven by evolving treatment paradigms, unmet medical needs, and the rising influence of technologies like pharmacogenomics, digital therapeutics...
10 Worst ARK Stocks To Buy According To Short Sellers
Investing comes in all sizes and flavors. For the risk averse investors that are looking for steady payouts or long term stability, value and dividend paying stocks are the way to go.
Pacific Biosciences of California, Inc. (NASDAQ:PACB) Q2 2024 Earnings Call Transcript
Operator: Good day and welcome to the PacBio Second Quarter 2024 Earnings Conference Call. All participants will be in a listen-only mode.
10 Micro Cap Stocks That Will Skyrocket
One of the more well known quotes of Warren Buffett is "Only buy something that you'd be perfectly happy to hold if the market shut down for 10 years." The learning from this quote is simple.
Top 10 Small-Cap Stocks with Highest Upside Potential
Most giant companies start as small-cap, but by continuously developing and growing their earnings, their share price increases making them large or mega-cap companies, and along the way smart investors...
Pacific Biosciences of California, Inc. (NASDAQ:PACB) Q1 2024 Earnings Call Transcript
Operator: Hello and welcome to the PacBio First Quarter 2024 Earnings Conference Call. All participants will be in a listen-only mode.
11 Oversold NASDAQ Stocks To Buy Right Now
In this article, we will be taking a look at 11 oversold NASDAQ stocks to buy right now.
Billionaire Hedge Funds
